Literature DB >> 21414886

Words of wisdom. Re: Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.

Philippe Beuzeboc1.   

Abstract

Entities:  

Year:  2011        PMID: 21414886     DOI: 10.1016/j.eururo.2011.01.021

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  1 in total

1.  Long Non-Coding RNA Landscape in Prostate Cancer Molecular Subtypes: A Feature Selection Approach.

Authors:  Simona De Summa; Antonio Palazzo; Mariapia Caputo; Rosa Maria Iacobazzi; Brunella Pilato; Letizia Porcelli; Stefania Tommasi; Angelo Virgilio Paradiso; Amalia Azzariti
Journal:  Int J Mol Sci       Date:  2021-02-23       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.